Marce, S., Xicoy, B., Garcia, O., Cabezon, M., Estrada, N., Velez, P., . . . Cron, G. E. L. M. (2021). Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
Citación estilo ChicagoMarce, S., et al. Impact of BCR-ABL1 Transcript Type On Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated With Imatinib. 2021.
Cita MLAMarce, S., et al. Impact of BCR-ABL1 Transcript Type On Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated With Imatinib. 2021.
Precaución: Estas citas no son 100% exactas.